Aspiriant LLC’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$747K Sell
2,760
-266
-9% -$79.2K 0.02% 183
2025
Q4
$999K Sell
3,026
-50
-2% -$16.9K 0.03% 157
2025
Q3
$1.06M Sell
3,076
-285
-8% -$86.2K 0.03% 142
2025
Q2
$1.05M Sell
3,361
-856
-20% -$327K 0.03% 145
2025
Q1
$2.21M Sell
4,217
-281
-6% -$144K 0.08% 90
2024
Q4
$2.28M Buy
4,498
+16
+0.4% +$9.09K 0.08% 90
2024
Q3
$2.62M Buy
4,482
+174
+4% +$98.4K 0.1% 85
2024
Q2
$2.19M Sell
4,308
-1,759
-29% -$862K 0.09% 86
2024
Q1
$3M Buy
6,067
+266
+5% +$135K 0.12% 77
2023
Q4
$3.05M Buy
5,801
+686
+13% +$366K 0.14% 69
2023
Q3
$2.58M Buy
5,115
+507
+11% +$250K 0.13% 75
2023
Q2
$2.22M Buy
4,608
+172
+4% +$84.1K 0.11% 87
2023
Q1
$2.1M Sell
4,436
-103
-2% -$49.7K 0.11% 85
2022
Q4
$2.41M Buy
4,539
+494
+12% +$262K 0.12% 77
2022
Q3
$2.04M Buy
4,045
+274
+7% +$144K 0.1% 82
2022
Q2
$1.94M Buy
3,771
+6
+0.2% +$3.01K 0.09% 83
2022
Q1
$1.92M Buy
3,765
+279
+8% +$135K 0.11% 90
2021
Q4
$1.75M Buy
3,486
+706
+25% +$320K 0.09% 94
2021
Q3
$1.08M Sell
2,780
-196
-7% -$81.2K 0.06% 114
2021
Q2
$1.19M Buy
2,976
+219
+8% +$87.3K 0.07% 102
2021
Q1
$1.02M Buy
2,757
+110
+4% +$38.1K 0.07% 104
2020
Q4
$928K Buy
2,647
+80
+3% +$26.8K 0.06% 106
2020
Q3
$799K Sell
2,567
-130
-5% -$39.9K 0.06% 116
2020
Q2
$796K Sell
2,697
-30
-1% -$8.6K 0.07% 101
2020
Q1
$679K Sell
2,727
-71
-3% -$19.5K 0.07% 103
2019
Q4
$822K Buy
2,798
+35
+1% +$9.16K 0.08% 104
2019
Q3
$601K Sell
2,763
-520
-16% -$125K 0.05% 132
2019
Q2
$802K Sell
3,283
-116
-3% -$27.9K 0.07% 127
2019
Q1
$840K Sell
3,399
-61
-2% -$15.6K 0.07% 120
2018
Q4
$862K Buy
3,460
+285
+9% +$75.3K 0.07% 112
2018
Q3
$845K Sell
3,175
-79
-2% -$20.5K 0.07% 117
2018
Q2
$798K Sell
3,254
-104
-3% -$25K 0.07% 124
2018
Q1
$719K Buy
+3,358
New +$767K 0.06% 124
2017
Q4
Sell
-1,594
Closed -$312K 171
2017
Q3
$312K Sell
1,594
-586
-27% -$113K 0.03% 161
2017
Q2
$404K Buy
2,180
+467
+27% +$81.9K 0.04% 155
2017
Q1
$280K Sell
1,713
-719
-30% -$118K 0.02% 177
2016
Q4
$389K Buy
2,432
+37
+2% +$5.53K 0.04% 148
2016
Q3
$335K Buy
+2,395
New +$335K 0.03% 159
2016
Q2
Sell
-2,735
Closed -$353K 191
2016
Q1
$353K Buy
+2,735
New +$324K 0.03% 147
2015
Q4
Sell
-4,843
Closed -$588K 94
2015
Q3
$588K Buy
4,843
+500
+12% +$59.8K 0.05% 63
2015
Q2
$530K Buy
+4,343
New +$514K 0.05% 72

Other funds holding UNH

Aspiriant LLC's UNH Position: Q1 2026 in Review

Aspiriant LLC reduced its UnitedHealth (UNH) stake by 8.8% in Q1 2026, selling an estimated $79.2K and leaving 2,760 shares worth $747K. The position accounts for 0.02% of the portfolio, ranked #183.

Aspiriant LLC first reported a position in UNH in Q2 2015 and has held it in 41 quarters since. The position peaked at $3.05M in Q4 2023. 3,019 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Aspiriant LLC held 2,760 shares of UnitedHealth worth $747K as of Q1 2026.
  • Aspiriant LLC sold 266 UnitedHealth shares in Q1 2026, an estimated $79.2K.
  • UnitedHealth made up 0.02% of Aspiriant LLC's portfolio in Q1 2026, its #183 holding.
  • Aspiriant LLC first reported a position in UnitedHealth in Q2 2015 and has held it in 41 quarters since.
  • Aspiriant LLC's UnitedHealth position peaked at $3.05M in Q4 2023.
  • 3,019 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.